Skip to main content

Hineline Lawrence J.'s Form 4 filing

Intra-Cellular Therapies, Inc. (ITCI) · filed Mar 13, 2023

Accession no.
0001209191-23-018284
Filed
Mar 13, 2023
Trade date
Mar 9-13, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions and 1 derivative transaction. Open-market sales total $925.2K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hineline Lawrence J.CIK 0001585697Officer (SVP of Finance CFO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 9, 2023Common StockAGrant or awardAcquired+15,663$0.00$015,663Direct
Mar 10, 2023Common StockSSaleDisposed−12,963$43.17−$559,612.712,700Direct
Mar 10, 2023Common StockSSaleDisposed−2,700$42.52−$114,8040Direct
Mar 10, 2023Common StockMOption exerciseAcquired+5,582––5,582Direct
Mar 13, 2023Common StockSSaleDisposed−5,324$44.97−$239,420.28258Direct
Mar 13, 2023Common StockSSaleDisposed−258$44.14−$11,388.120Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 10, 2023Common StockMOption exerciseDisposed−5,582$0.00$011,164Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)